NDA Partners Chairman Carl Peck, MD, announced today that Robert Peterson, RAC, a regulatory affairs and program management executive with more than 33 years of regulatory and product development experience in the biopharmaceutical and medical device industries, has joined the firm as an Expert Consultant.
ROCHELLE, VA. (PRWEB) NOVEMBER 13, 2019
NDA Partners Chairman Carl Peck, MD, announced today that Robert Peterson, RAC, a regulatory affairs and program management executive with more than 33 years of regulatory and product development experience in the biopharmaceutical and medical device industries, has joined the firm as an Expert Consultant.
Robert Peterson has extensive experience in formulating and executing regulatory, clinical, and product development strategies, interfacing with regulatory agencies, and filing regulatory submissions. In addition, he has extensive hands-on experience in research and development, manufacturing, nonclinical and clinical studies, and leading cross-functional teams in both small and large companies.
Most recently, Mr. Peterson was Executive Director of Regulatory Affairs at Liquidia Technologies Inc. He has also served as Vice President of Product Development and Regulatory Affairs at Nephrogenex Inc., Director of Research and Development at Cardiopolymers Inc., and Director of Product Development at Biostratum Inc. In his early career, he served as Director of Research and Development in the Vascular Division at Baxter Healthcare.
“Mr. Peterson’s extensive experience leading cross-functional regulatory and product development teams in both small and large companies will bring great value to our clients who need full support for their product development programs,” said Dr. Peck. “We are pleased to welcome him to NDA Partners.”
Robert Peterson earned his Master of Engineering degree in biomedical engineering from the University of California, Berkeley and his Bachelor of Science degree in engineering from the United States Military Academy at West Point, New York.
About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
[email protected]
Mr. Peterson’s extensive experience leading cross-functional regulatory and product development teams in both small and large companies will bring great value to our clients who need full support for their product development programs.
